This ASO approach allows us to circumvent the postnatal lethality of global Mboat7 deletion (Lee et al., 2012; Anderson et al., 2013), and permits investigation into obesity-linked liver disease progression with near complete loss of function of Mboat7 in the liver. The gene discussed is MBOAT7; the disease is obesity due to melanocortin 4 receptor deficiency.